MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Lupin
Lupin
BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 31, 14:06
533.45
4.4 (0.83%)
VOLUME 12,134
LIVE
NSE
May 31, 14:06
533.45
4.4 (0.83%)
VOLUME 165,435
Management Interviews on Lupin
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Expect strong growth from US in FY13-14: Lupin 

12.56 pm | 18 May 2012 |  Source: CNBC-TV18

Lupin’s CFO S Ramesh tells CNBC-TV18 that he anticipates strong growth in FY13-14 from US....

Lupin to focus on new product infusion in FY13 

5.48 pm | 10 May 2012 |  Source: CNBC-TV18

Higher tax expenses led to a decline in consolidated net profit of pharma company, Lupin in the fourth quarter of FY12. The company posted a decline o...

1
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.